Flotrin Uro contains the active substance terazosin which belongs to a group of medicines (alfa-1-receptor blockers) that relieve the symptoms of benign prostatic hyperplasia and emptying of the bladder.
Flotrin Uro is used for the treatment of:
• concerns (clinical symptoms) and urinary symptoms associated with benign prostatic hyperplasia (BPH).